Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32983
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDelorme, Mathieu-
dc.contributor.authorLeotard, Antoine-
dc.contributor.authorLebret, Marius-
dc.contributor.authorLefeuvre, Claire-
dc.contributor.authorHazenberg, Anda-
dc.contributor.authorPallero, Mercedes-
dc.contributor.authorNickol, Annabel H-
dc.contributor.authorHannan, Liam M-
dc.contributor.authorBoentert, Matthias-
dc.contributor.authorYüksel, Aycan-
dc.contributor.authorWindisch, Wolfram-
dc.contributor.authorHoward, Mark E-
dc.contributor.authorHart, Nicholas-
dc.contributor.authorWijkstra, Peter J-
dc.contributor.authorPrigent, Hélène-
dc.contributor.authorPepin, Jean-Louis-
dc.contributor.authorLofaso, Frederic-
dc.contributor.authorKhouri, Charles-
dc.contributor.authorBorel, Jean-Christian-
dc.date2023-05-
dc.date.accessioned2023-06-07T02:37:20Z-
dc.date.available2023-06-07T02:37:20Z-
dc.date.issued2023-08-
dc.identifier.citationArchivos de Bronconeumologia 2023-08; 59(8)en_US
dc.identifier.issn1579-2129-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32983-
dc.description.abstractHome noninvasive ventilation (NIV), targeting a reduction of carbon dioxide with a combination of sufficient inspiratory support and backup-rate improves outcomes in patients with chronic obstructive pulmonary disease. The aim of this systematic review with individual participant data (IPD) meta-analysis was to evaluate the effects of intensity of home NIV on respiratory outcomes in individuals with slowly progressive neuromuscular (NMD) or chest-wall disorders (CWD). Controlled, non-controlled and cohort studies indexed between January-2000 and December-2020 were sought from Medline, Embase and the Cochrane Central Register. Outcomes were diurnal PaCO2, PaO2, daily NIV usage, and interface type (PROSPERO-CRD 42021245121). NIV intensity was defined according to the Z-score of the product of pressure support (or tidal volume) and backup-rate. 16 eligible studies were identified; we obtained IPD for 7 studies (176 participants: 113-NMD; 63-CWD). The reduction in PaCO2 was greater with higher baseline PaCO2. NIV intensity per se was not associated with improved PaCO2 except in individuals with CWD and the most severe baseline hypercapnia. Similar results were found for PaO2. Daily NIV usage was associated with improvement in gas exchange but not with NIV intensity. No association between NIV intensity and interface type was found. Following home NIV initiation in NMD or CWD patients, no relationship was observed between NIV intensity and PaCO2, except in individuals with the most severe CWD. The amount of daily NIV usage, rather than intensity, is key to improving hypoventilation in this population during the first few months after introduction of therapy.en_US
dc.language.isoeng-
dc.subjectChest wall disordersen_US
dc.subjectMeta-analysisen_US
dc.subjectNeuromuscular diseasesen_US
dc.subjectNoninvasive ventilationen_US
dc.subjectSystematic reviewen_US
dc.titleEffect of Intensity of Home Noninvasive Ventilation in Individuals With Neuromuscular and Chest Wall Disorders: A Systematic Review and Meta-Analysis of Individual Participant Data.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleArchivos de Bronconeumologiaen_US
dc.identifier.affiliationUniversité Paris-Saclay, UVSQ, ERPHAN, 78000 Versailles, Franceen_US
dc.identifier.affiliationService de Physiologie et explorations fonctionnelles, GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), 92380 Garches, Franceen_US
dc.identifier.affiliationUniversity of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands.en_US
dc.identifier.affiliationNeurology Department, Raymond Poincaré University Hospital, Garches, APHP, Franceen_US
dc.identifier.affiliationUniversity of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Department of Home Mechanical Ventilation, Groningen, The Netherlandsen_US
dc.identifier.affiliationRespiratory Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spainen_US
dc.identifier.affiliationOxford Centre for Respiratory Medicine, Oxford University Hospital NHS Foundation Trust, Oxford OX3 7LE, UKen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Northern Health, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Neurology, Münster University Hospital (UKM), Münster, Germanyen_US
dc.identifier.affiliationUfuk University, Faculty of Medicine, Rıdvan Ege Hospital, Department of Pulmonology and Tuberculosis, Ankara, Turkey.en_US
dc.identifier.affiliationCologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln, gGmbH, Witten/Herdecke University, Germany.en_US
dc.identifier.affiliationInstitute for Breathing and Sleepen_US
dc.identifier.affiliationLane Fox Clinical Respiratory Physiology Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UKen_US
dc.identifier.affiliationHP2 (Hypoxia and Physio-Pathologies) Laboratory, Inserm (French National Institute of Health and Medical Research) U1300, University Grenoble Alpes, Grenoble, Franceen_US
dc.identifier.affiliationResearch and Development Department, AGIR à dom Association, 36 Bd du Vieux Chêne, 38240 Meylan, France.en_US
dc.identifier.affiliationCentre Régional de pharmacovigilance, Centre d'Investigation Clinique, CHU Grenoble Alpes, France.en_US
dc.identifier.affiliationNord-Est-Ile-de-France Neuromuscular Reference Center, FHU PHENIX, France.en_US
dc.identifier.affiliationAFM-Téléthon, Direction des Actions Médicales, 91000 Evry, Franceen_US
dc.identifier.affiliationCIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.en_US
dc.identifier.affiliationThe Royal Brompton Hospital, London SW3 6NP, UK.en_US
dc.identifier.affiliationDept of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Medicine, UKM-Marienhospital Steinfurt, Steinfurt, Germany.en_US
dc.identifier.affiliationTurner Institute for Brain and Mental Health, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationCentre for Human and Applied Physiological Science, King's College London, London, UK.en_US
dc.identifier.affiliationFHU Phenix - GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), 92380 Garches, France.en_US
dc.identifier.affiliationEFCR (Cardiovascular and Respiratory Function) Laboratory, Grenoble Alpes University Hospital, Grenoble, France.en_US
dc.identifier.doi10.1016/j.arbres.2023.05.002en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37217384-
local.name.researcherHannan, Liam M-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptInstitute for Breathing and Sleep-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

76
checked on Dec 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.